theheart.org: Latest Clinical Cardiology medical news

Editorial series

Life and times of leading cardiologists with Rob Califf. Guest: Bob Harrington

Nov 6, 2009 09:50 EST

Raised in a blue-collar neighborhood of Somerville, MA, Dr Bob Harrington was blessed to have a strong family and the Jesuits on his side as he traveled from "Yankee" Boston to Duke University. Join him as he tells his story to Dr Rob Califf.

Editorial series

Clinical research: Comparing regulatory pathways in US and UK

Oct 30, 2009 12:35 EDT

How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.

Editorial series

Afib treatment: The five-year plan

Oct 23, 2009 10:40 EDT

Dr Melissa Walton-Shirley talks to Dr Nassir Marrouche about the results of RE-LY, the impact of dronedarone on the treatment of atrial fibrillation, and his hopes for the future of MRI-guided ablation.

Editorial series

All about ARBs: From Kyoto to Barcelona

Oct 16, 2009 10:00 EDT

Join heartwire's Lisa Nainggolan as she talks to Drs Franz Messerli and Melissa Walton-Shirley about the results of the KYOTO HEART Study, what they mean for North American and European populations, and the future role of angiotensin-receptor blockers (ARBs).

Editorial series

Life and times of leading cardiologists with Rob Califf. Guest: Peter Sleight

2 COMMENTS - Oct 13, 2009 10:15 EDT

With the ISIS-1 trial, Dr Peter Sleight and his team at Oxford changed the approach to cardiovascular research. Join Dr Robert Califf as he talks to Dr Sleight about his journey from London to San Francisco to Oxford and finally to Italy, where he discovered the music of the heart.

Editorial series

Tips for building the ideal lab for transcatheter-valve procedures

1 COMMENT - Oct 7, 2009 09:26 EDT

Drs Bonhoeffer and Kovac discuss size, sterility, location, presence of multidisciplinary teams, and imaging techniques - issues to consider in creating an ideal lab that can also adapt to future technologies and developments.

Editorial series

Cardiac resynchronization therapy: Update from ESC

Oct 2, 2009 13:45 EDT

Join 'heartwire's Steve Stiles as he talks to Drs Nassir Marrouche and Clyde Yancy about MADIT-CRT, the potential benefits and costs for the heart-failure population in light of the trial, and about why the Europeans seem to be ahead of the guidelines in the European CRT Survey.

Editorial series

The lowdown on high blood pressure

1 COMMENT - Sep 28, 2009 14:10 EDT

Is there an ideal blood-pressure goal? theheart.org's Dr Melissa Walton-Shirley catches up with hypertension expert and current president of the American Society of Hypertension, Dr Henry Black, to address this thorny issue and others.

Editorial series

DES firestorm: The fallout since 2006

Sep 22, 2009 11:50 EDT

Exactly three years after the DES firestorm ignited the World Congress of Cardiology in Barcelona, heartwire's Shelley Wood sifts through the ashes with Drs Tony Gershlick, Christian Spaulding, and Renu Virmani in a discussion on DES safety and what we've learned since September 2006.

Editorial series

ACC and AHA: Leadership in today's healthcare environment

Sep 15, 2009 14:10 EDT

Dr Robert Califf sits down with Drs Alfred Bove, Jack Lewin, and Clyde Yancy and AHA CEO Nancy Brown to talk about the ACC and the AHA and their role in the debate on healthcare reform.

The Cardiology Show

Best of Barcelona: PLATO and RE-LY

Sep 2, 2009 11:15 EDT

Dr Valentin Fuster returns to the city where he was born for a scintillating discussion with Drs Fox, Gershlick, Marrouche, Messerli, Spaulding, Vergheugt, Virmani, and Yancy about the miracle of RE-LY and the striking success of ticagrelor in the PLATO study.

Editorial series

PROTECT-AF: A world without warfarin?

8 COMMENTS - Jul 14, 2009 13:36 EDT

Join Drs Melissa Walton-Shirley, Ann Curtis, and Cindy Grines for an overview of PROTECT-AF and their thoughts on the future of the Watchman device.

Editorial series

Understanding SYNTAX

Jun 29, 2009 11:00 EDT

Dr Robert Harrington talks to Drs Sanjay Kaul and Harlan Kurmholz about the SYNTAX trial in light of the recent quality-of-life and cost analysis.

Editorial series

Getting to the bottom of BARI 2D

3 COMMENTS - Jun 25, 2009 00:03 EDT

Join Drs Valentin Fuster, William E Boden, and George D Dangas as they discuss the results, plus the evolution of therapy over the last forty years, the mechanisms of coronary artery disease progression in diabetic patients, and what is perhaps one of the most fundamental problems in the field: that patients today are still not treated to target with best medical therapy.

Editorial series

After TIPS: What's next for the polypill?

1 COMMENT - Jun 15, 2009 09:30 EDT

Join Drs Salim Yusuf and Sanjay Kaul for an in-depth discussion on the promise and prospects of the polypill moderated by heartwire's Lisa Nainggolan.

Editorial series

Hypertrophic cardiomyopathy, athletes, and screening

Jun 5, 2009 09:30 EDT

Is it possible and desirable to envisage a nationwide system to screen athletes for hypertrophic cardiomyopathy? Drs Ommen, Maron, and Thompson examine the Italian screening data and review the implications of this model for the US.

Editorial series

Life and times of leading cardiologists with Rob Califf. Guest: Steve Nissen

1 COMMENT - Jun 1, 2009 10:20 EDT

Join Dr Robert Califf for a probing and personal interview with Dr Steve Nissen, about his activist days at the University of Michigan and the development of IVUS, to how he ended up at the Cleveland Clinic and what he thinks about the future of medicine in America.

Editorial series

Strategies for GP IIb/IIIa blockers after EARLY ACS

May 22, 2009 09:20 EDT

Dr Harlan Krumholz talks to Drs Sanjay Kaul and Robert Harrington about EARLY ACS and the issues around upstream use of GP IIb/IIIa inhibitors.

Editorial series

Cardiac catheterization access sites: An international perspective

1 COMMENT - Apr 29, 2009 00:00 EDT

With the global trend leaning toward increased use of transradial access, our international panel reports on standard practice at their respective institutions and the key issues that influence it such as bleeding, access-site complications, stroke risk, patient mobility, and operator experience. Join Drs Kandzari (US), Feres (Brazil), Le May (Canada), and Steg (France) for this thoughtful and practical discussion.

The Cardiology Show

ACC 2009: From the eye of the storm in Orlando

Apr 2, 2009 15:35 EDT

Join Drs Valentin Fuster, Anne Curtis, Timothy Gardner, Barry Greenberg, Cindy Grines, Bob Harrington, Sanjay Kaul, Harlan Krumholz, and Salim Yusuf as they unravel the STICH trial and debate the lessons learned from PROTECT-AF in Part 1 of the Cardiology Show. In Part 2 of the program, the JUPITER trial is back on the table and our experts give their opinion on the polypill following the results of the TIPS study.

Editorial series

Lipid lowering: The end or the means?

4 COMMENTS - Dec 9, 2008 16:46 EST

Dr Blumenthal talks to Drs Krumholz, Ridker, and Smith about how to approach target guidelines for LDL in the wake of JUPITER, SEARCH, and other lipid-lowering studies.

Ten years in review

Reviewing 10 years of cardiology news

1 COMMENT - Dec 3, 2008 14:30 EST

As theheart.org enters its 10th year join editor-in-chief, Dr Eric Topol, and his guests for a second look at the top news from the past decade. Throughout the coming months, we'll revisit the most important story from each of the last 10 years and ask: How has practice been affected? With time and perspective, what has changed and what have we learned?

Cardiology panels

Cardiovascular implications of treating type 2 diabetes, post-APPROACH

5 COMMENTS - Dec 3, 2008 09:30 EST

How best to treat patients presenting with both coronary disease and diabetes? Join Drs Nesto and Fonseca on this rather slippery slope as they examine the data and provide practical guidance for treatment.

The Cardiology Show

AHA 2008: The AHA Flies to JUPITER

3 COMMENTS - Nov 14, 2008 12:00 EST

Join Drs Krumholz, Blumenthal, Harrington, Jessup, Ridker, Smith, Stone, Weintraub, and Yancy as they dissect the results of the JUPITER and debate the far-reaching clinical implications of this landmark study in Part 1 of the program. In Part 2, the panelists look at the positive sides of HF-Action and TIMACS and deliberate the real lessons learned from these negative trials.

Cardiology panels

The media response to ENHANCE

Jun 2, 2008 14:22 EDT

Join heartwire's Larry Husten as he talks to Dr Harlan Krumholz and USA Today journalist Steve Sternberg about the decision to present the results of the ENHANCE trial at a unique opening session of the ACC 2008 Scientific Sessions, and about the response of the cardiology community and the media to the continuing controversy.

	No
	Yes